Biblio Discovery — Demo Discovery Service

6 results for "Roderick B. Walker"

Showing 1–6 · 0.76 seconds · RSS

  1. Journal Article

    The use of QbD for the development and validation of a stability-indicating RP-HPLC method for the quantitation of nevirapine in bulk, tablet and niosome formulations

    Bwalya A. Witika; Roderick B. Walker

    Frontiers in Analytical Science, Vol. 6 · 2026 · English · DOAJ Scopus

    IntroductionA reversed-phase high-performance liquid chromatographic (RP-HPLC) method was developed and validated for the quantitation of nevirapine (NVP) in bulk drug, commercial tablets, and niosome formulations using an Analytical Quality by Design (AQbD) approach.MethodsCritical analytical…

  2. Journal Article Full text

    Adjunctive Multicomponent Crystals of Two Anti-Tubercular Drugs with Pyridoxine

    Tsebang A. Matlapeng; Theodor E. Geswindt; Roderick B. Walker et al.

    Pharmaceutics, Vol. 18 No. 3 · 2026 · English · DOAJ Scopus

    Background/Objectives: Cocrystallisation is a well-established path for altering the physicochemical properties and bioavailability of active pharmaceutical ingredients (APIs). A common side effect of anti-tubercular medicines is the depletion of group B vitamin reserves in TB patients…

  3. Journal Article Full text

    Innovative Strategies for Combating Multidrug-Resistant Tuberculosis: Advances in Drug Delivery Systems and Treatment

    Omobolanle A. Omoteso; Adewale O. Fadaka; Roderick B. Walker et al.

    Microorganisms, Vol. 13 No. 4 · 2025 · English · DOAJ Scopus

    Multidrug-resistant tuberculosis (MDR-TB) is a significant public health challenge globally, exacerbated by the limited efficacy of existing therapeutic approaches, prolonged treatment duration, and severe side effects. As drug resistance continues to emerge, innovative drug delivery systems and…

  4. Journal Article Full text

    Design, Manufacturing, Characterization and Evaluation of Lipid Nanocapsules to Enhance the Biopharmaceutical Properties of Efavirenz

    Grady K. Mukubwa; Justin B. Safari; Roderick B. Walker et al.

    Pharmaceutics, Vol. 14 No. 7 · 2022 · English · DOAJ Scopus

    Despite their incredible contribution to fighting viral infections, antiviral viral resistance is an increasing concern and often arises due to unfavorable physicochemical and biopharmaceutical properties. To address this kind of issue, lipid nanocapsules (LNC) are developed in this study, using…

  5. Journal Article Full text

    Chitosan-Coated SLN: A Potential System for Ocular Delivery of Metronidazole

    Simise S. Sikhondze; Pedzisai A. Makoni; Roderick B. Walker et al.

    Pharmaceutics, Vol. 15 No. 7 · 2023 · English · DOAJ Scopus

    Ophthalmic drops for ocular delivery exhibit inadequate residence time, which often requires multiple daily dosing that may result in patient non-adherence. In this study, the development of a once-daily-dosed chitosan-coated metronidazole (MTZ)-loaded solid lipid nanoparticles (SLNs) for ocular…

  6. Journal Article

    Lipid nanocapsule-chitosan and iota-carrageenan hydrogel composite for sustained hydrophobic drug delivery

    Grady K. Mukubwa; Justin B. Safari; Zikhona N. Tetana et al.

    Scientific Reports, Vol. 15 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Hydrophobic drug delivery via oral routes presents significant challenges for clinical translation, particularly for poorly soluble antiviral drugs. Physiological barriers, such as enzymatic degradation, harsh pH, and rapid transit in the gastrointestinal tract, or mucociliary clearance…